CFI.co – Capital Finance International: Campaign Raises Awareness of Migraine on Women’s Careers

Migraine is the leading reason for lost work days for people under 50 — and women are three times more likely than men to suffer from the disorder. “Migraine hits mostly women in their prime working years (and) addressing it is a must.” Maria Teresa Ferretti, Women’s Brain Project

The launch of Not All In Her Head marks an important step in the fight for greater awareness. The Not All in her Head campaign encourages policymakers, patients, healthcare professionals, employers and the general public to adopt a multi-stakeholder approach to improve migraine management with better awareness, early diagnosis, and gender-specific research.

Learn more in the CFI.co article here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Return Home

Make a Donation

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.